Does tocilizumab have an effect on the clinical outcomes in COVID-19 patients? A meta-analysis of randomized control trials

BACKGROUND: This meta-analysis was conducted to investigate the impact of tocilizumab on clinical outcomes associated with COVID-19. METHODS: A comprehensive search was conducted across Scopus, PubMed (Medline), Cochrane Library, EMBASE (Elsevier), ClinicalTrials.gov, and Web of Sciences to identify...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghaempanah, Faezeh, Nikouei, Maziar, Cheraghi, Mojtaba, Jahangiri, Arman, Moradi, Yousef
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10658795/
https://www.ncbi.nlm.nih.gov/pubmed/37986199
http://dx.doi.org/10.1186/s40545-023-00662-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10658795/
https://www.ncbi.nlm.nih.gov/pubmed/37986199
http://dx.doi.org/10.1186/s40545-023-00662-w

Ejemplares similares